TekhnovoTekhnovo
Tekhnovo

Tekhnovo

Teknova provides critical reagents for biopharmaceutical product development and production.

2023Inactive182
Rate

About

Teknova is a life sciences company that manufactures critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics. They offer customizable solutions for various stages of workflow, from research to GMP production, supporting areas like cell and gene therapy, mRNA therapeutics, and genomics.

Technology stack

detected 2026-05-22
Est. monthly stack spend~$1,270/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Tekhnovo do?

Teknova is a life sciences company that manufactures critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics. They offer customizable solutions for various stages of workflow, from research to GMP production, supporting areas like cell and gene therapy, mRNA therapeutics, and genomics.

Where is Tekhnovo headquartered?

Tekhnovo is headquartered in United Kingdom.

When was Tekhnovo founded?

Tekhnovo was founded in 2023.

What industry does Tekhnovo operate in?

Tekhnovo operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.

How many employees does Tekhnovo have?

Tekhnovo has approximately 182 people on record.

What is Tekhnovo's current status?

Tekhnovo's current operating status is: Inactive.